Covid-19 Impact on Global Intravenous (IV) Iron Therapy Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/covid-19-impact-on-global-intravenous-iv-iron-therapy-market-size-status-n-forecast-2020-2026_en.gif)
This report focuses on the global Intravenous (IV) Iron Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Intravenous (IV) Iron Therapy development in North America, Europe, China and Japan.
The key players covered in this study
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, product type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
The key players covered in this study
- Sanofi
- Allergan
- AMAG Pharmaceuticals
- Dalichi Sankyo
- Luitpold Pharmaceuticals
- Pharmacosmos
- Takeda Pharmaceutical
- ...
- Ferric Carboxymaltose
- Iron Sucrose
- Iron Dextran
- Others
- Nephrology
- Gynecology & Obstetrics
- Gastroenterology
- Oncology
- Cardiology
- Others
- North America
- Europe
- China
- Japan
- To analyze global Intravenous (IV) Iron Therapy status, future forecast, growth opportunity, key market and key players.
- To present the Intravenous (IV) Iron Therapy development in North America, Europe, China and Japan.
- To define, describe and forecast the market by product type, market and key regions.
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, product type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Intravenous (IV) Iron Therapy Revenue
1.4 Covid-19 Implications on Market by Product Type
1.4.1 Global Intravenous (IV) Iron Therapy Market Size Growth Rate by Product Type: 2020 VS 2026
1.4.2 Ferric Carboxymaltose
1.4.3 Iron Sucrose
1.4.4 Iron Dextran
1.4.5 Others
1.5 Covid-19 Implications on Market by Application
1.5.1 Global Intravenous (IV) Iron Therapy Market Share by Application: 2020 VS 2026
1.5.2 Nephrology
1.5.3 Gynecology & Obstetrics
1.5.4 Gastroenterology
1.5.5 Oncology
1.5.6 Cardiology
1.5.7 Others
1.6 Coronavirus Disease 2019 (Covid-19): Intravenous (IV) Iron Therapy Industry Impact
1.6.1 How the Covid-19 is Affecting the Intravenous (IV) Iron Therapy Industry
1.6.1.1 Intravenous (IV) Iron Therapy Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Intravenous (IV) Iron Therapy Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Intravenous (IV) Iron Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Covid-19 Implications on Global Intravenous (IV) Iron Therapy Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Intravenous (IV) Iron Therapy Growth Trends by Regions
2.2.1 Intravenous (IV) Iron Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Intravenous (IV) Iron Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Intravenous (IV) Iron Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Intravenous (IV) Iron Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Intravenous (IV) Iron Therapy Players (Opinion Leaders)
3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Intravenous (IV) Iron Therapy Players by Market Size
3.1.1 Global Top Intravenous (IV) Iron Therapy Players by Revenue (2015-2020)
3.1.2 Global Intravenous (IV) Iron Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Intravenous (IV) Iron Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Intravenous (IV) Iron Therapy Market Concentration Ratio
3.2.1 Global Intravenous (IV) Iron Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Intravenous (IV) Iron Therapy Revenue in 2019
3.3 Intravenous (IV) Iron Therapy Key Players Head office and Area Served
3.4 Key Players Intravenous (IV) Iron Therapy Product Solution and Service
3.5 Date of Enter into Intravenous (IV) Iron Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 COVID-19 IMPLICATIONS ON MARKET SIZE BY PRODUCT TYPE (2015-2026)
4.1 Global Intravenous (IV) Iron Therapy Historic Market Size by Product Type (2015-2020)
4.2 Global Intravenous (IV) Iron Therapy Forecasted Market Size by Product Type (2021-2026)
5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)
5.1 Global Intravenous (IV) Iron Therapy Market Size by Application (2015-2020)
5.2 Global Intravenous (IV) Iron Therapy Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Intravenous (IV) Iron Therapy Market Size (2015-2020)
6.2 Intravenous (IV) Iron Therapy Key Players in North America (2019-2020)
6.3 North America Intravenous (IV) Iron Therapy Market Size by Product Type (2015-2020)
6.4 North America Intravenous (IV) Iron Therapy Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Intravenous (IV) Iron Therapy Market Size (2015-2020)
7.2 Intravenous (IV) Iron Therapy Key Players in Europe (2019-2020)
7.3 Europe Intravenous (IV) Iron Therapy Market Size by Product Type (2015-2020)
7.4 Europe Intravenous (IV) Iron Therapy Market Size by Application (2015-2020)
8 CHINA
8.1 China Intravenous (IV) Iron Therapy Market Size (2015-2020)
8.2 Intravenous (IV) Iron Therapy Key Players in China (2019-2020)
8.3 China Intravenous (IV) Iron Therapy Market Size by Product Type (2015-2020)
8.4 China Intravenous (IV) Iron Therapy Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Intravenous (IV) Iron Therapy Market Size (2015-2020)
9.2 Intravenous (IV) Iron Therapy Key Players in Japan (2019-2020)
9.3 Japan Intravenous (IV) Iron Therapy Market Size by Product Type (2015-2020)
9.4 Japan Intravenous (IV) Iron Therapy Market Size by Application (2015-2020)
10KEY PLAYERS PROFILES
10.1 Sanofi
10.1.1 Sanofi Company Details
10.1.2 Sanofi Business Overview and Its Total Revenue
10.1.3 Sanofi Intravenous (IV) Iron Therapy Introduction
10.1.4 Sanofi Revenue in Intravenous (IV) Iron Therapy Business (2015-2020))
10.1.5 Sanofi Recent Development
10.2 Allergan
10.2.1 Allergan Company Details
10.2.2 Allergan Business Overview and Its Total Revenue
10.2.3 Allergan Intravenous (IV) Iron Therapy Introduction
10.2.4 Allergan Revenue in Intravenous (IV) Iron Therapy Business (2015-2020)
10.2.5 Allergan Recent Development
10.3 AMAG Pharmaceuticals
10.3.1 AMAG Pharmaceuticals Company Details
10.3.2 AMAG Pharmaceuticals Business Overview and Its Total Revenue
10.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Introduction
10.3.4 AMAG Pharmaceuticals Revenue in Intravenous (IV) Iron Therapy Business (2015-2020)
10.3.5 AMAG Pharmaceuticals Recent Development
10.4 Dalichi Sankyo
10.4.1 Dalichi Sankyo Company Details
10.4.2 Dalichi Sankyo Business Overview and Its Total Revenue
10.4.3 Dalichi Sankyo Intravenous (IV) Iron Therapy Introduction
10.4.4 Dalichi Sankyo Revenue in Intravenous (IV) Iron Therapy Business (2015-2020)
10.4.5 Dalichi Sankyo Recent Development
10.5 Luitpold Pharmaceuticals
10.5.1 Luitpold Pharmaceuticals Company Details
10.5.2 Luitpold Pharmaceuticals Business Overview and Its Total Revenue
10.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Introduction
10.5.4 Luitpold Pharmaceuticals Revenue in Intravenous (IV) Iron Therapy Business (2015-2020)
10.5.5 Luitpold Pharmaceuticals Recent Development
10.6 Pharmacosmos
10.6.1 Pharmacosmos Company Details
10.6.2 Pharmacosmos Business Overview and Its Total Revenue
10.6.3 Pharmacosmos Intravenous (IV) Iron Therapy Introduction
10.6.4 Pharmacosmos Revenue in Intravenous (IV) Iron Therapy Business (2015-2020)
10.6.5 Pharmacosmos Recent Development
10.7 Takeda Pharmaceutical
10.7.1 Takeda Pharmaceutical Company Details
10.7.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
10.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Therapy Introduction
10.7.4 Takeda Pharmaceutical Revenue in Intravenous (IV) Iron Therapy Business (2015-2020)
10.7.5 Takeda Pharmaceutical Recent Development
11ANALYST'S VIEWPOINTS/CONCLUSIONS
12APPENDIX
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Intravenous (IV) Iron Therapy Revenue
1.4 Covid-19 Implications on Market by Product Type
1.4.1 Global Intravenous (IV) Iron Therapy Market Size Growth Rate by Product Type: 2020 VS 2026
1.4.2 Ferric Carboxymaltose
1.4.3 Iron Sucrose
1.4.4 Iron Dextran
1.4.5 Others
1.5 Covid-19 Implications on Market by Application
1.5.1 Global Intravenous (IV) Iron Therapy Market Share by Application: 2020 VS 2026
1.5.2 Nephrology
1.5.3 Gynecology & Obstetrics
1.5.4 Gastroenterology
1.5.5 Oncology
1.5.6 Cardiology
1.5.7 Others
1.6 Coronavirus Disease 2019 (Covid-19): Intravenous (IV) Iron Therapy Industry Impact
1.6.1 How the Covid-19 is Affecting the Intravenous (IV) Iron Therapy Industry
1.6.1.1 Intravenous (IV) Iron Therapy Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Intravenous (IV) Iron Therapy Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Intravenous (IV) Iron Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Covid-19 Implications on Global Intravenous (IV) Iron Therapy Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Intravenous (IV) Iron Therapy Growth Trends by Regions
2.2.1 Intravenous (IV) Iron Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Intravenous (IV) Iron Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Intravenous (IV) Iron Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Intravenous (IV) Iron Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Intravenous (IV) Iron Therapy Players (Opinion Leaders)
3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Intravenous (IV) Iron Therapy Players by Market Size
3.1.1 Global Top Intravenous (IV) Iron Therapy Players by Revenue (2015-2020)
3.1.2 Global Intravenous (IV) Iron Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Intravenous (IV) Iron Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Intravenous (IV) Iron Therapy Market Concentration Ratio
3.2.1 Global Intravenous (IV) Iron Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Intravenous (IV) Iron Therapy Revenue in 2019
3.3 Intravenous (IV) Iron Therapy Key Players Head office and Area Served
3.4 Key Players Intravenous (IV) Iron Therapy Product Solution and Service
3.5 Date of Enter into Intravenous (IV) Iron Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 COVID-19 IMPLICATIONS ON MARKET SIZE BY PRODUCT TYPE (2015-2026)
4.1 Global Intravenous (IV) Iron Therapy Historic Market Size by Product Type (2015-2020)
4.2 Global Intravenous (IV) Iron Therapy Forecasted Market Size by Product Type (2021-2026)
5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)
5.1 Global Intravenous (IV) Iron Therapy Market Size by Application (2015-2020)
5.2 Global Intravenous (IV) Iron Therapy Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Intravenous (IV) Iron Therapy Market Size (2015-2020)
6.2 Intravenous (IV) Iron Therapy Key Players in North America (2019-2020)
6.3 North America Intravenous (IV) Iron Therapy Market Size by Product Type (2015-2020)
6.4 North America Intravenous (IV) Iron Therapy Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Intravenous (IV) Iron Therapy Market Size (2015-2020)
7.2 Intravenous (IV) Iron Therapy Key Players in Europe (2019-2020)
7.3 Europe Intravenous (IV) Iron Therapy Market Size by Product Type (2015-2020)
7.4 Europe Intravenous (IV) Iron Therapy Market Size by Application (2015-2020)
8 CHINA
8.1 China Intravenous (IV) Iron Therapy Market Size (2015-2020)
8.2 Intravenous (IV) Iron Therapy Key Players in China (2019-2020)
8.3 China Intravenous (IV) Iron Therapy Market Size by Product Type (2015-2020)
8.4 China Intravenous (IV) Iron Therapy Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Intravenous (IV) Iron Therapy Market Size (2015-2020)
9.2 Intravenous (IV) Iron Therapy Key Players in Japan (2019-2020)
9.3 Japan Intravenous (IV) Iron Therapy Market Size by Product Type (2015-2020)
9.4 Japan Intravenous (IV) Iron Therapy Market Size by Application (2015-2020)
10KEY PLAYERS PROFILES
10.1 Sanofi
10.1.1 Sanofi Company Details
10.1.2 Sanofi Business Overview and Its Total Revenue
10.1.3 Sanofi Intravenous (IV) Iron Therapy Introduction
10.1.4 Sanofi Revenue in Intravenous (IV) Iron Therapy Business (2015-2020))
10.1.5 Sanofi Recent Development
10.2 Allergan
10.2.1 Allergan Company Details
10.2.2 Allergan Business Overview and Its Total Revenue
10.2.3 Allergan Intravenous (IV) Iron Therapy Introduction
10.2.4 Allergan Revenue in Intravenous (IV) Iron Therapy Business (2015-2020)
10.2.5 Allergan Recent Development
10.3 AMAG Pharmaceuticals
10.3.1 AMAG Pharmaceuticals Company Details
10.3.2 AMAG Pharmaceuticals Business Overview and Its Total Revenue
10.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Therapy Introduction
10.3.4 AMAG Pharmaceuticals Revenue in Intravenous (IV) Iron Therapy Business (2015-2020)
10.3.5 AMAG Pharmaceuticals Recent Development
10.4 Dalichi Sankyo
10.4.1 Dalichi Sankyo Company Details
10.4.2 Dalichi Sankyo Business Overview and Its Total Revenue
10.4.3 Dalichi Sankyo Intravenous (IV) Iron Therapy Introduction
10.4.4 Dalichi Sankyo Revenue in Intravenous (IV) Iron Therapy Business (2015-2020)
10.4.5 Dalichi Sankyo Recent Development
10.5 Luitpold Pharmaceuticals
10.5.1 Luitpold Pharmaceuticals Company Details
10.5.2 Luitpold Pharmaceuticals Business Overview and Its Total Revenue
10.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Therapy Introduction
10.5.4 Luitpold Pharmaceuticals Revenue in Intravenous (IV) Iron Therapy Business (2015-2020)
10.5.5 Luitpold Pharmaceuticals Recent Development
10.6 Pharmacosmos
10.6.1 Pharmacosmos Company Details
10.6.2 Pharmacosmos Business Overview and Its Total Revenue
10.6.3 Pharmacosmos Intravenous (IV) Iron Therapy Introduction
10.6.4 Pharmacosmos Revenue in Intravenous (IV) Iron Therapy Business (2015-2020)
10.6.5 Pharmacosmos Recent Development
10.7 Takeda Pharmaceutical
10.7.1 Takeda Pharmaceutical Company Details
10.7.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
10.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Therapy Introduction
10.7.4 Takeda Pharmaceutical Revenue in Intravenous (IV) Iron Therapy Business (2015-2020)
10.7.5 Takeda Pharmaceutical Recent Development
11ANALYST'S VIEWPOINTS/CONCLUSIONS
12APPENDIX
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
LIST OF TABLES
Table 1. Intravenous (IV) Iron Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Intravenous (IV) Iron Therapy Revenue
Table 3. Ranking of Global Top Intravenous (IV) Iron Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Intravenous (IV) Iron Therapy Market Size Growth Rate by Product Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Ferric Carboxymaltose
Table 6. Key Players of Iron Sucrose
Table 7. Key Players of Iron Dextran
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Intravenous (IV) Iron Therapy Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Intravenous (IV) Iron Therapy Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Intravenous (IV) Iron Therapy Players to Combat Covid-19 Impact
Table 14. Global Intravenous (IV) Iron Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Intravenous (IV) Iron Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Intravenous (IV) Iron Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Intravenous (IV) Iron Therapy Market Share by Regions (2015-2020)
Table 18. Global Intravenous (IV) Iron Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Intravenous (IV) Iron Therapy Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Intravenous (IV) Iron Therapy Market Growth Strategy
Table 24. Main Points Interviewed from Key Intravenous (IV) Iron Therapy Players
Table 25. Global Intravenous (IV) Iron Therapy Revenue by Players (2015-2020) (Million US$)
Table 26. Global Intravenous (IV) Iron Therapy Market Share by Players (2015-2020)
Table 27. Global Top Intravenous (IV) Iron Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous (IV) Iron Therapy as of 2019)
Table 28. Global Intravenous (IV) Iron Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Intravenous (IV) Iron Therapy Product Solution and Service
Table 31. Date of Enter into Intravenous (IV) Iron Therapy Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Intravenous (IV) Iron Therapy Market Size by Product Type (2015-2020) (Million US$)
Table 34. Global Intravenous (IV) Iron Therapy Market Size Share by Product Type (2015-2020)
Table 35. Global Intravenous (IV) Iron Therapy Revenue Market Share by Product Type (2021-2026)
Table 36. Global Intravenous (IV) Iron Therapy Market Size Share by Application (2015-2020)
Table 37. Global Intravenous (IV) Iron Therapy Market Size by Application (2015-2020) (Million US$)
Table 38. Global Intravenous (IV) Iron Therapy Market Size Share by Application (2021-2026)
Table 39. North America Key Players Intravenous (IV) Iron Therapy Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Intravenous (IV) Iron Therapy Market Share (2019-2020)
Table 41. North America Intravenous (IV) Iron Therapy Market Size by Product Type (2015-2020) (Million US$)
Table 42. North America Intravenous (IV) Iron Therapy Market Share by Product Type (2015-2020)
Table 43. North America Intravenous (IV) Iron Therapy Market Size by Application (2015-2020) (Million US$)
Table 44. North America Intravenous (IV) Iron Therapy Market Share by Application (2015-2020)
Table 45. Europe Key Players Intravenous (IV) Iron Therapy Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Intravenous (IV) Iron Therapy Market Share (2019-2020)
Table 47. Europe Intravenous (IV) Iron Therapy Market Size by Product Type (2015-2020) (Million US$)
Table 48. Europe Intravenous (IV) Iron Therapy Market Share by Product Type (2015-2020)
Table 49. Europe Intravenous (IV) Iron Therapy Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Intravenous (IV) Iron Therapy Market Share by Application (2015-2020)
Table 51. China Key Players Intravenous (IV) Iron Therapy Revenue (2019-2020) (Million US$)
Table 52. China Key Players Intravenous (IV) Iron Therapy Market Share (2019-2020)
Table 53. China Intravenous (IV) Iron Therapy Market Size by Product Type (2015-2020) (Million US$)
Table 54. China Intravenous (IV) Iron Therapy Market Share by Product Type (2015-2020)
Table 55. China Intravenous (IV) Iron Therapy Market Size by Application (2015-2020) (Million US$)
Table 56. China Intravenous (IV) Iron Therapy Market Share by Application (2015-2020)
Table 57. Japan Key Players Intravenous (IV) Iron Therapy Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Intravenous (IV) Iron Therapy Market Share (2019-2020)
Table 59. Japan Intravenous (IV) Iron Therapy Market Size by Product Type (2015-2020) (Million US$)
Table 60. Japan Intravenous (IV) Iron Therapy Market Share by Product Type (2015-2020)
Table 61. Japan Intravenous (IV) Iron Therapy Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Intravenous (IV) Iron Therapy Market Share by Application (2015-2020)
Table 63. Sanofi Company Details
Table 64. Sanofi Business Overview
Table 65. Sanofi Product
Table 66. Sanofi Revenue in Intravenous (IV) Iron Therapy Business (2015-2020) (Million US$)
Table 67. Sanofi Recent Development
Table 68. Allergan Company Details
Table 69. Allergan Business Overview
Table 70. Allergan Product
Table 71. Allergan Revenue in Intravenous (IV) Iron Therapy Business (2015-2020) (Million US$)
Table 72. Allergan Recent Development
Table 73. AMAG Pharmaceuticals Company Details
Table 74. AMAG Pharmaceuticals Business Overview
Table 75. AMAG Pharmaceuticals Product
Table 76. AMAG Pharmaceuticals Revenue in Intravenous (IV) Iron Therapy Business (2015-2020) (Million US$)
Table 77. AMAG Pharmaceuticals Recent Development
Table 78. Dalichi Sankyo Company Details
Table 79. Dalichi Sankyo Business Overview
Table 80. Dalichi Sankyo Product
Table 81. Dalichi Sankyo Revenue in Intravenous (IV) Iron Therapy Business (2015-2020) (Million US$)
Table 82. Dalichi Sankyo Recent Development
Table 83. Luitpold Pharmaceuticals Company Details
Table 84. Luitpold Pharmaceuticals Business Overview
Table 85. Luitpold Pharmaceuticals Product
Table 86. Luitpold Pharmaceuticals Revenue in Intravenous (IV) Iron Therapy Business (2015-2020) (Million US$)
Table 87. Luitpold Pharmaceuticals Recent Development
Table 88. Pharmacosmos Company Details
Table 89. Pharmacosmos Business Overview
Table 90. Pharmacosmos Product
Table 91. Pharmacosmos Revenue in Intravenous (IV) Iron Therapy Business (2015-2020) (Million US$)
Table 92. Pharmacosmos Recent Development
Table 93. Takeda Pharmaceutical Company Details
Table 94. Takeda Pharmaceutical Business Overview
Table 95. Takeda Pharmaceutical Product
Table 96. Takeda Pharmaceutical Revenue in Intravenous (IV) Iron Therapy Business (2015-2020) (Million US$)
Table 97. Takeda Pharmaceutical Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 1. Intravenous (IV) Iron Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Intravenous (IV) Iron Therapy Revenue
Table 3. Ranking of Global Top Intravenous (IV) Iron Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Intravenous (IV) Iron Therapy Market Size Growth Rate by Product Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Ferric Carboxymaltose
Table 6. Key Players of Iron Sucrose
Table 7. Key Players of Iron Dextran
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Intravenous (IV) Iron Therapy Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Intravenous (IV) Iron Therapy Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Intravenous (IV) Iron Therapy Players to Combat Covid-19 Impact
Table 14. Global Intravenous (IV) Iron Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Intravenous (IV) Iron Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Intravenous (IV) Iron Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Intravenous (IV) Iron Therapy Market Share by Regions (2015-2020)
Table 18. Global Intravenous (IV) Iron Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Intravenous (IV) Iron Therapy Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Intravenous (IV) Iron Therapy Market Growth Strategy
Table 24. Main Points Interviewed from Key Intravenous (IV) Iron Therapy Players
Table 25. Global Intravenous (IV) Iron Therapy Revenue by Players (2015-2020) (Million US$)
Table 26. Global Intravenous (IV) Iron Therapy Market Share by Players (2015-2020)
Table 27. Global Top Intravenous (IV) Iron Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous (IV) Iron Therapy as of 2019)
Table 28. Global Intravenous (IV) Iron Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Intravenous (IV) Iron Therapy Product Solution and Service
Table 31. Date of Enter into Intravenous (IV) Iron Therapy Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Intravenous (IV) Iron Therapy Market Size by Product Type (2015-2020) (Million US$)
Table 34. Global Intravenous (IV) Iron Therapy Market Size Share by Product Type (2015-2020)
Table 35. Global Intravenous (IV) Iron Therapy Revenue Market Share by Product Type (2021-2026)
Table 36. Global Intravenous (IV) Iron Therapy Market Size Share by Application (2015-2020)
Table 37. Global Intravenous (IV) Iron Therapy Market Size by Application (2015-2020) (Million US$)
Table 38. Global Intravenous (IV) Iron Therapy Market Size Share by Application (2021-2026)
Table 39. North America Key Players Intravenous (IV) Iron Therapy Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Intravenous (IV) Iron Therapy Market Share (2019-2020)
Table 41. North America Intravenous (IV) Iron Therapy Market Size by Product Type (2015-2020) (Million US$)
Table 42. North America Intravenous (IV) Iron Therapy Market Share by Product Type (2015-2020)
Table 43. North America Intravenous (IV) Iron Therapy Market Size by Application (2015-2020) (Million US$)
Table 44. North America Intravenous (IV) Iron Therapy Market Share by Application (2015-2020)
Table 45. Europe Key Players Intravenous (IV) Iron Therapy Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Intravenous (IV) Iron Therapy Market Share (2019-2020)
Table 47. Europe Intravenous (IV) Iron Therapy Market Size by Product Type (2015-2020) (Million US$)
Table 48. Europe Intravenous (IV) Iron Therapy Market Share by Product Type (2015-2020)
Table 49. Europe Intravenous (IV) Iron Therapy Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Intravenous (IV) Iron Therapy Market Share by Application (2015-2020)
Table 51. China Key Players Intravenous (IV) Iron Therapy Revenue (2019-2020) (Million US$)
Table 52. China Key Players Intravenous (IV) Iron Therapy Market Share (2019-2020)
Table 53. China Intravenous (IV) Iron Therapy Market Size by Product Type (2015-2020) (Million US$)
Table 54. China Intravenous (IV) Iron Therapy Market Share by Product Type (2015-2020)
Table 55. China Intravenous (IV) Iron Therapy Market Size by Application (2015-2020) (Million US$)
Table 56. China Intravenous (IV) Iron Therapy Market Share by Application (2015-2020)
Table 57. Japan Key Players Intravenous (IV) Iron Therapy Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Intravenous (IV) Iron Therapy Market Share (2019-2020)
Table 59. Japan Intravenous (IV) Iron Therapy Market Size by Product Type (2015-2020) (Million US$)
Table 60. Japan Intravenous (IV) Iron Therapy Market Share by Product Type (2015-2020)
Table 61. Japan Intravenous (IV) Iron Therapy Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Intravenous (IV) Iron Therapy Market Share by Application (2015-2020)
Table 63. Sanofi Company Details
Table 64. Sanofi Business Overview
Table 65. Sanofi Product
Table 66. Sanofi Revenue in Intravenous (IV) Iron Therapy Business (2015-2020) (Million US$)
Table 67. Sanofi Recent Development
Table 68. Allergan Company Details
Table 69. Allergan Business Overview
Table 70. Allergan Product
Table 71. Allergan Revenue in Intravenous (IV) Iron Therapy Business (2015-2020) (Million US$)
Table 72. Allergan Recent Development
Table 73. AMAG Pharmaceuticals Company Details
Table 74. AMAG Pharmaceuticals Business Overview
Table 75. AMAG Pharmaceuticals Product
Table 76. AMAG Pharmaceuticals Revenue in Intravenous (IV) Iron Therapy Business (2015-2020) (Million US$)
Table 77. AMAG Pharmaceuticals Recent Development
Table 78. Dalichi Sankyo Company Details
Table 79. Dalichi Sankyo Business Overview
Table 80. Dalichi Sankyo Product
Table 81. Dalichi Sankyo Revenue in Intravenous (IV) Iron Therapy Business (2015-2020) (Million US$)
Table 82. Dalichi Sankyo Recent Development
Table 83. Luitpold Pharmaceuticals Company Details
Table 84. Luitpold Pharmaceuticals Business Overview
Table 85. Luitpold Pharmaceuticals Product
Table 86. Luitpold Pharmaceuticals Revenue in Intravenous (IV) Iron Therapy Business (2015-2020) (Million US$)
Table 87. Luitpold Pharmaceuticals Recent Development
Table 88. Pharmacosmos Company Details
Table 89. Pharmacosmos Business Overview
Table 90. Pharmacosmos Product
Table 91. Pharmacosmos Revenue in Intravenous (IV) Iron Therapy Business (2015-2020) (Million US$)
Table 92. Pharmacosmos Recent Development
Table 93. Takeda Pharmaceutical Company Details
Table 94. Takeda Pharmaceutical Business Overview
Table 95. Takeda Pharmaceutical Product
Table 96. Takeda Pharmaceutical Revenue in Intravenous (IV) Iron Therapy Business (2015-2020) (Million US$)
Table 97. Takeda Pharmaceutical Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Intravenous (IV) Iron Therapy Market Share by Product Type: 2020 VS 2026
Figure 2. Ferric Carboxymaltose Features
Figure 3. Iron Sucrose Features
Figure 4. Iron Dextran Features
Figure 5. Others Features
Figure 6. Global Intravenous (IV) Iron Therapy Market Share by Application: 2020 VS 2026
Figure 7. Nephrology Case Studies
Figure 8. Gynecology & Obstetrics Case Studies
Figure 9. Gastroenterology Case Studies
Figure 10. Oncology Case Studies
Figure 11. Cardiology Case Studies
Figure 12. Others Case Studies
Figure 13. Intravenous (IV) Iron Therapy Report Years Considered
Figure 14. Global Intravenous (IV) Iron Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Intravenous (IV) Iron Therapy Market Share by Regions: 2020 VS 2026
Figure 16. Global Intravenous (IV) Iron Therapy Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Intravenous (IV) Iron Therapy Market Share by Players in 2019
Figure 19. Global Top Intravenous (IV) Iron Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous (IV) Iron Therapy as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Intravenous (IV) Iron Therapy Revenue in 2019
Figure 21. North America Intravenous (IV) Iron Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Intravenous (IV) Iron Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Intravenous (IV) Iron Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Intravenous (IV) Iron Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Sanofi Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2015-2020)
Figure 27. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Allergan Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2015-2020)
Figure 29. AMAG Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. AMAG Pharmaceuticals Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2015-2020)
Figure 31. Dalichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Dalichi Sankyo Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2015-2020)
Figure 33. Luitpold Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Luitpold Pharmaceuticals Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2015-2020)
Figure 35. Pharmacosmos Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Pharmacosmos Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2015-2020)
Figure 37. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Takeda Pharmaceutical Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
Figure 1. Global Intravenous (IV) Iron Therapy Market Share by Product Type: 2020 VS 2026
Figure 2. Ferric Carboxymaltose Features
Figure 3. Iron Sucrose Features
Figure 4. Iron Dextran Features
Figure 5. Others Features
Figure 6. Global Intravenous (IV) Iron Therapy Market Share by Application: 2020 VS 2026
Figure 7. Nephrology Case Studies
Figure 8. Gynecology & Obstetrics Case Studies
Figure 9. Gastroenterology Case Studies
Figure 10. Oncology Case Studies
Figure 11. Cardiology Case Studies
Figure 12. Others Case Studies
Figure 13. Intravenous (IV) Iron Therapy Report Years Considered
Figure 14. Global Intravenous (IV) Iron Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Intravenous (IV) Iron Therapy Market Share by Regions: 2020 VS 2026
Figure 16. Global Intravenous (IV) Iron Therapy Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Intravenous (IV) Iron Therapy Market Share by Players in 2019
Figure 19. Global Top Intravenous (IV) Iron Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous (IV) Iron Therapy as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Intravenous (IV) Iron Therapy Revenue in 2019
Figure 21. North America Intravenous (IV) Iron Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Intravenous (IV) Iron Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Intravenous (IV) Iron Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Intravenous (IV) Iron Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Sanofi Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2015-2020)
Figure 27. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Allergan Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2015-2020)
Figure 29. AMAG Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. AMAG Pharmaceuticals Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2015-2020)
Figure 31. Dalichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Dalichi Sankyo Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2015-2020)
Figure 33. Luitpold Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Luitpold Pharmaceuticals Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2015-2020)
Figure 35. Pharmacosmos Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Pharmacosmos Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2015-2020)
Figure 37. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Takeda Pharmaceutical Revenue Growth Rate in Intravenous (IV) Iron Therapy Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed